Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry

Sreekanth Vemulapalli, David Dai, Bradley G. Hammill, Suzanne J. Baron, David J. Cohen, Michael J. Mack, David Holmes

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Patients with severe aortic stenosis (AS) have repeat hospitalizations for multiple conditions. Objectives: The purpose of this study was to assess the effect of transcatheter aortic valve replacement (TAVR) on hospitalizations in severe AS. Methods: Using data from the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) registry with linkage to Medicare claims, the authors examined rates of all-cause, cardiovascular, and noncardiovascular hospitalizations and hospital days, as well as inpatient costs in the year pre-TAVR and post-TAVR. Multivariable modeling was used to determine rate ratios of post-TAVR versus pre-TAVR hospitalizations and costs. Results: Among 15,324 patients at 328 sites with Medicare linkage undergoing TAVR, the median age was 84 years, the median Society of Thoracic Surgeons Predicted Risk of Mortality score was 7.0, and 61.1% patients underwent TAVR via transfemoral access. Post-TAVR, heart failure hospitalization rates and hospitalized days were reduced compared with pre-TAVR (rate ratio: 0.87 and 0.95 respectively; p < 0.01 for all). However, all-cause, noncardiovascular, and bleeding hospitalization rates and hospitalized days were increased (p < 0.01 for all). Post-TAVR hospitalizations were reduced the most among those with left ventricular ejection fraction <30%. Mean post-TAVR costs were reduced among all TAVR patients and among 1-year survivors (rate ratio: 0.95, p < 0.01; and 0.90; p < 0.01, respectively). Conclusions: Patients had lower costs and fewer heart failure hospitalizations but more all-cause, noncardiovascular, and bleeding hospitalizations post-TAVR. Reduction in hospitalizations varied by specific patient subgroups, and thus, payors and providers seeking to reduce resource use may consider strategies designed to improve processes of care among patients with increased resource utilization post-TAVR as compared with pre-TAVR.

Original languageEnglish (US)
Pages (from-to)1135-1146
Number of pages12
JournalJournal of the American College of Cardiology
Volume73
Issue number10
DOIs
StatePublished - Mar 19 2019

Fingerprint

Registries
Hospitalization
Therapeutics
Costs and Cost Analysis
Aortic Valve Stenosis
Transcatheter Aortic Valve Replacement
Medicare
Heart Failure
Hemorrhage
Stroke Volume
Survivors
Inpatients
Patient Care

Keywords

  • bleeding
  • costs
  • heart failure
  • hospitalizations
  • Medicare
  • transcatheter aortic valve replacement

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement : The STS/ACC TVT Registry. / Vemulapalli, Sreekanth; Dai, David; Hammill, Bradley G.; Baron, Suzanne J.; Cohen, David J.; Mack, Michael J.; Holmes, David.

In: Journal of the American College of Cardiology, Vol. 73, No. 10, 19.03.2019, p. 1135-1146.

Research output: Contribution to journalArticle

Vemulapalli, Sreekanth ; Dai, David ; Hammill, Bradley G. ; Baron, Suzanne J. ; Cohen, David J. ; Mack, Michael J. ; Holmes, David. / Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement : The STS/ACC TVT Registry. In: Journal of the American College of Cardiology. 2019 ; Vol. 73, No. 10. pp. 1135-1146.
@article{98804779fc054460a9ec414d8f45f17a,
title = "Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement: The STS/ACC TVT Registry",
abstract = "Background: Patients with severe aortic stenosis (AS) have repeat hospitalizations for multiple conditions. Objectives: The purpose of this study was to assess the effect of transcatheter aortic valve replacement (TAVR) on hospitalizations in severe AS. Methods: Using data from the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) registry with linkage to Medicare claims, the authors examined rates of all-cause, cardiovascular, and noncardiovascular hospitalizations and hospital days, as well as inpatient costs in the year pre-TAVR and post-TAVR. Multivariable modeling was used to determine rate ratios of post-TAVR versus pre-TAVR hospitalizations and costs. Results: Among 15,324 patients at 328 sites with Medicare linkage undergoing TAVR, the median age was 84 years, the median Society of Thoracic Surgeons Predicted Risk of Mortality score was 7.0, and 61.1{\%} patients underwent TAVR via transfemoral access. Post-TAVR, heart failure hospitalization rates and hospitalized days were reduced compared with pre-TAVR (rate ratio: 0.87 and 0.95 respectively; p < 0.01 for all). However, all-cause, noncardiovascular, and bleeding hospitalization rates and hospitalized days were increased (p < 0.01 for all). Post-TAVR hospitalizations were reduced the most among those with left ventricular ejection fraction <30{\%}. Mean post-TAVR costs were reduced among all TAVR patients and among 1-year survivors (rate ratio: 0.95, p < 0.01; and 0.90; p < 0.01, respectively). Conclusions: Patients had lower costs and fewer heart failure hospitalizations but more all-cause, noncardiovascular, and bleeding hospitalizations post-TAVR. Reduction in hospitalizations varied by specific patient subgroups, and thus, payors and providers seeking to reduce resource use may consider strategies designed to improve processes of care among patients with increased resource utilization post-TAVR as compared with pre-TAVR.",
keywords = "bleeding, costs, heart failure, hospitalizations, Medicare, transcatheter aortic valve replacement",
author = "Sreekanth Vemulapalli and David Dai and Hammill, {Bradley G.} and Baron, {Suzanne J.} and Cohen, {David J.} and Mack, {Michael J.} and David Holmes",
year = "2019",
month = "3",
day = "19",
doi = "10.1016/j.jacc.2018.12.049",
language = "English (US)",
volume = "73",
pages = "1135--1146",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Hospital Resource Utilization Before and After Transcatheter Aortic Valve Replacement

T2 - The STS/ACC TVT Registry

AU - Vemulapalli, Sreekanth

AU - Dai, David

AU - Hammill, Bradley G.

AU - Baron, Suzanne J.

AU - Cohen, David J.

AU - Mack, Michael J.

AU - Holmes, David

PY - 2019/3/19

Y1 - 2019/3/19

N2 - Background: Patients with severe aortic stenosis (AS) have repeat hospitalizations for multiple conditions. Objectives: The purpose of this study was to assess the effect of transcatheter aortic valve replacement (TAVR) on hospitalizations in severe AS. Methods: Using data from the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) registry with linkage to Medicare claims, the authors examined rates of all-cause, cardiovascular, and noncardiovascular hospitalizations and hospital days, as well as inpatient costs in the year pre-TAVR and post-TAVR. Multivariable modeling was used to determine rate ratios of post-TAVR versus pre-TAVR hospitalizations and costs. Results: Among 15,324 patients at 328 sites with Medicare linkage undergoing TAVR, the median age was 84 years, the median Society of Thoracic Surgeons Predicted Risk of Mortality score was 7.0, and 61.1% patients underwent TAVR via transfemoral access. Post-TAVR, heart failure hospitalization rates and hospitalized days were reduced compared with pre-TAVR (rate ratio: 0.87 and 0.95 respectively; p < 0.01 for all). However, all-cause, noncardiovascular, and bleeding hospitalization rates and hospitalized days were increased (p < 0.01 for all). Post-TAVR hospitalizations were reduced the most among those with left ventricular ejection fraction <30%. Mean post-TAVR costs were reduced among all TAVR patients and among 1-year survivors (rate ratio: 0.95, p < 0.01; and 0.90; p < 0.01, respectively). Conclusions: Patients had lower costs and fewer heart failure hospitalizations but more all-cause, noncardiovascular, and bleeding hospitalizations post-TAVR. Reduction in hospitalizations varied by specific patient subgroups, and thus, payors and providers seeking to reduce resource use may consider strategies designed to improve processes of care among patients with increased resource utilization post-TAVR as compared with pre-TAVR.

AB - Background: Patients with severe aortic stenosis (AS) have repeat hospitalizations for multiple conditions. Objectives: The purpose of this study was to assess the effect of transcatheter aortic valve replacement (TAVR) on hospitalizations in severe AS. Methods: Using data from the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) registry with linkage to Medicare claims, the authors examined rates of all-cause, cardiovascular, and noncardiovascular hospitalizations and hospital days, as well as inpatient costs in the year pre-TAVR and post-TAVR. Multivariable modeling was used to determine rate ratios of post-TAVR versus pre-TAVR hospitalizations and costs. Results: Among 15,324 patients at 328 sites with Medicare linkage undergoing TAVR, the median age was 84 years, the median Society of Thoracic Surgeons Predicted Risk of Mortality score was 7.0, and 61.1% patients underwent TAVR via transfemoral access. Post-TAVR, heart failure hospitalization rates and hospitalized days were reduced compared with pre-TAVR (rate ratio: 0.87 and 0.95 respectively; p < 0.01 for all). However, all-cause, noncardiovascular, and bleeding hospitalization rates and hospitalized days were increased (p < 0.01 for all). Post-TAVR hospitalizations were reduced the most among those with left ventricular ejection fraction <30%. Mean post-TAVR costs were reduced among all TAVR patients and among 1-year survivors (rate ratio: 0.95, p < 0.01; and 0.90; p < 0.01, respectively). Conclusions: Patients had lower costs and fewer heart failure hospitalizations but more all-cause, noncardiovascular, and bleeding hospitalizations post-TAVR. Reduction in hospitalizations varied by specific patient subgroups, and thus, payors and providers seeking to reduce resource use may consider strategies designed to improve processes of care among patients with increased resource utilization post-TAVR as compared with pre-TAVR.

KW - bleeding

KW - costs

KW - heart failure

KW - hospitalizations

KW - Medicare

KW - transcatheter aortic valve replacement

UR - http://www.scopus.com/inward/record.url?scp=85062268985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062268985&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2018.12.049

DO - 10.1016/j.jacc.2018.12.049

M3 - Article

C2 - 30871697

AN - SCOPUS:85062268985

VL - 73

SP - 1135

EP - 1146

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 10

ER -